Market News & Trends
Beroni Group Advances Research & Development of Medical Solution for Coronavirus (COVID-19)
Beroni Group recently announced its development of a medical solution using nanobody technology for the novel coronavirus (COVID-19) in collaboration with Tianjin University in China…
Arcturus Therapeutics & Duke-NUS Medical School Partner to Develop a COVID-19 Vaccine
Arcturus Therapeutics and Duke-NUS Medical School (Duke-NUS) recently announced their partnership to develop a Coronavirus….
PDC*line Pharma Announces First Patient Dosed With its Therapeutic Cancer Vaccine
PDC*line Pharma recently announced the first patient was dosed with its innovative medicinal product candidate PDC*lung01 in a Phase 1/2 trial in….
zPREDICTA Enters Strategic Collaboration With LabCorp
zPREDICTA, Inc. recently announce it has entered into a strategic collaboration with LabCorpto to support the adoption of….
ADMA Biologics Highlights Expanded Intellectual Property Portfolio
ADMA Biologics recently announced that it has received another Notice of Allowance from the US Patent and Trademark Office (USPTO) for a patent application related to its…..
Worldwide Research & Collaboration Needed to Combat Covid-19
In light of the coronavirus (COVID-19) outbreak, leading data and analytics company GlobalData has analyzed several of the largest COVID-19 clinical trials in terms of…
Itamar Medical & Clalit Research Institute Establish Research Collaboration
Itamar Medical Ltd. recently announced it has entered into a research collaboration agreement with Clalit Research Institute (CRI), a subsidiary of Clalit Health Services (CHS),…
TTP Enters Exclusive License Agreement With DiaSorin
TTP plc and DiaSorin have recently signed an exclusive license and technology transfer agreement. DiaSorin will combine its extensive molecular test offering with TTP’s Puckdx…
Evelo Biosciences Announces Biomarker Data Showing Drug is Orally Delivered Dual Cytokine Inhibitor for Inflammatory Diseases
Evelo Biosciences, Inc. recently announced biomarker data for EDP1815, its lead inflammation product candidate. Interim data from individuals in the ongoing Phase 1b clinical trial…
CN Bio Innovations Raises $9 Million to Strengthen Commercial Development
CN Bio Innovations recently announced it has raised $9 million investment, led by CITIC Securities Investment Co., Ltd., and supported by existing investor CN Innovations…
Bormioli Pharma Speeds Up on Innovation With H-FARM
Fast prototyping and an approach to innovation focused on customer needs are at the heart of the innovation path undertaken by Bormioli Pharma alongside H-FARM.…
Pii Expands Aseptic Filling Capabilities With Fully Robotic Filling Line
Pharmaceutics International, Inc. (Pii), a pharmaceutical contract development and manufacturing organization (CDMO), recently announced the expansion of its aseptic filling capacity and….
Oramed Reports Positive Results in the Final Cohort of its Phase 2b Oral Insulin Trial
Oramed Pharmaceuticals Inc. recently announced positive topline data from the second and final cohort of its Phase 2b trial evaluating the efficacy and safety of its lead…
Novavax Advances Development of Novel COVID-19 Vaccine
Novavax, Inc. recently announced progress in its efforts to develop a novel vaccine to protect against coronavirus disease COVID-19….
Arecor Achieves Second License Milestone Payment From Global Pharmaceutical Partner
Arecor Ltd recently announced it has achieved an important second, contractual milestone with one of its pharmaceutical partners….
Alimera Sciences Meets Revenue Milestone & Accesses Additional $2.5 Million
Alimera Sciences, Inc. recently announced it has drawn down the remaining $2.5 million under the $45-million term loan agreement with its current lenders, investment affiliates managed by…..
TrakCel & Ori Biotech Sign Collaboration Agreement
TrakCel and Ori Biotech Ltd recently announced a non-exclusive strategic partnership to achieve supply chain orchestration within closed system manufacturing for the cell and gene therapy sector.…
Theralase Advances Its Pivotal Phase 2 Non-Muscle Invasive Bladder Cancer Study
Theralase Technologies Inc. recently announced that Nova Scotia Health Authority (NSHA) Research Ethics Board (REB) has approved the commencement of a Pivotal Phase 2 Non-Muscle…
Spring Bank Announces New Clinical Collaboration With Roche
Spring Bank Pharmaceuticals, Inc. recently announced a new clinical collaboration with Roche to explore the co-administration of SB 11285, Spring Bank's intravenously (IV)-administered STING (STimulator…
Perrigo & Catalent Announce FDA Approval
Perrigo Company plc and its partner Catalent Pharma Solutions recently announced the US FDA has approved Perrigo’s abbreviated new drug application for generic albuterol sulfate…
